Jaya Sukses Makmur Sentosa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Jaya Sukses Makmur Sentosa Tbk. trades at Rp800 (market cap 13.04T, 1.26M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jaya Sukses Makmur Sentosa Tbk. is far larger — about 124.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RISE | SCPI | |
|---|---|---|
Market Cap | 13.04T | 104.4B |
Volume | 1.26M | — |
Lot | 12.59K | — |
Turnover | 1.01B | — |
Average Price | 799.21 | — |
Value | 1.01B | — |
Indicative Equilibrium Price | 800 | — |
Indicative Equilibrium Volume | 78 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Jaya Sukses Makmur Sentosa Tbk (the Company) was established based on Notarial Deed No. 18 of Choiriyah, S.H., dated May 23, 2003.
Read more on RISE →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →